Company patents
Apollon Inc.
Apollon Inc. surprisingly shows a near-exclusive focus on Material & Chemical Analysis (100.0% of its portfolio) and Medical Diagnostics & Surgery (97.4%), despite these core areas experiencing significant declines in patenting activity, with Material & Chemical Analysis down 33.3% YoY in 2025 and Medical Diagnostics & Surgery down 38.1% YoY in 2025, and further substantial drops so far in 2026. This suggests a shifting priority away from its established strengths, with Photometry / Spectrometry emerging as a minor but stable focus, maintaining 2 patents in both 2025 and so far in 2026.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
39 US filings (since 2023) · 3 categories · 2 themes
Methods and compositions for identifying, quantifying, or characterizing specific biological molecules (e.g., nucleic acids, proteins, metabolites, antibodies) or microbial species, often for diagnostic, prognostic, or quality control applications.
Techniques and apparatus utilizing various spectroscopy methods (e.g., Raman, NIRS, photometric, interferometric) for identifying substances, measuring concentrations, or monitoring chemical and physical processes in industrial, environmental, or laboratory settings.
Patents
Showing 1-4 of 4
Spectroscopic Material & Process Analysis